Skip to main content
Year archive

Oncopeptides — 2025 filings

All 54 regulatory filings released by Oncopeptides (ONCO) in 2025, sourced directly from the official regulator.

54 Filings
2025 Period
2025 filings (54)
Filing Released Lang
Oncopeptides har utsett valberedningen
Regulatory Filings
2025-11-21 Swedish
Oncopeptides announces the Nomination Committee
Regulatory Filings
2025-11-21 English
Interim / Quarterly Report 2025
Interim / Quarterly Report Q3 2025
2025-11-05 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Q3 2025
2025-11-05 English
Antal aktier och röster i Oncopeptides
Share Issue/Capital Change
2025-10-31 Swedish
Number of shares and votes in Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2025-10-31 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-28 Swedish
Oncopeptides issues warrants to fulfil its obligations under loan agreement with EIB
Capital/Financing Update
2025-10-13 English
Oncopeptides emitterar teckningsoptioner för att uppfylla sina skyldigheter under låneavtal med EIB
Capital/Financing Update
2025-10-13 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-10 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-08 Swedish
Antal aktier och röster i Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2025-09-30 Swedish
Number of shares and votes in Oncopeptides
Share Issue/Capital Change
2025-09-30 English
Oncopeptides’ rights issue oversubscribed to approximately 157 percent
Share Issue/Capital Change
2025-09-17 English
Oncopeptides företrädesemission övertecknad till cirka 157 procent
Share Issue/Capital Change
2025-09-17 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-29 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-28 Swedish
Oncopeptides publishes disclosure document regarding rights issue
Report Publication Announcement
2025-08-28 English
Oncopeptides offentliggör informationsdokument avseende företrädesemission
Report Publication Announcement
2025-08-28 Swedish
Oncopeptides enters into additional guarantee commitments, rights issue fully guaranteed
Share Issue/Capital Change
2025-08-25 English
Oncopeptides ingår ytterligare garantiåtaganden, företrädesemissionen fullt garanterad
Share Issue/Capital Change
2025-08-25 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-25 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Q2 2025
2025-08-21 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Q2 2025
2025-08-21 English
Oncopeptides carries out rights issue of approximately SEK 150 million and provides update regarding the potential partnership in Japan
Share Issue/Capital Change
2025-08-21 English
Oncopeptides genomför företrädesemission om cirka 150 MSEK och ger en uppdatering om det potentiella partnerskapet i Japan
Share Issue/Capital Change
2025-08-21 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-13 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-07 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-05 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-22 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-18 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-14 Swedish
Oncopeptides announces net sales for Q2 2025
Earnings Release Q2 2025
2025-07-09 English
Oncopeptides offentliggör försäljning för andra kvartalet 2025
Earnings Release Q2 2025
2025-07-09 Swedish
Kommuniké från årsstämma i Oncopeptides AB (publ)
AGM Information
2025-05-22 Swedish
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
AGM Information
2025-05-22 English
Interim / Quarterly Report 2025
Interim / Quarterly Report Q1 2025
2025-05-15 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Q1 2025
2025-05-15 English
Annual Report (ESEF) 2024
Annual Report (ESEF) FY 2024
2025-04-28 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-22 Swedish
Annual General Meeting in Oncopeptides AB (publ)
Proxy Solicitation & Information Statement
2025-04-16 English
Årsstämma i Oncopeptides AB (publ)
Proxy Solicitation & Information Statement
2025-04-16 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-10 Swedish
Director's Dealing 2025
Director's Dealing
2025-03-03 Swedish
Antal aktier och röster i Oncopeptides
Share Issue/Capital Change
2025-02-28 Swedish
Number of shares and votes in Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2025-02-28 English
Correction: Issue and re-purchase of class C shares for shareholder program
Capital/Financing Update
2025-02-28 English
Rättelse: Emission och återköp av C-aktier för aktieägarprogram
Transaction in Own Shares
2025-02-28 Swedish
Issue and re-purchase of class C shares for shareholder program
Transaction in Own Shares
2025-02-27 English
Emission och återköp av C-aktier för aktieägarprogram
Share Issue/Capital Change
2025-02-27 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q4 2024
2025-02-27 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q4 2024
2025-02-27 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-01-13 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-01-13 Swedish